William J. Caragol, Chairman and CEO of PositiveID (PSID), called into SmallCapVoice.com to discuss revised strategy, released by the Department of Homeland Security. Updated Strategy Consists of a Two-Stage Procurement, the First Stage of Which is Planned to Begin Later This Year With the Release of Draft Request for Proposal.
PSID Believes it is Well Positioned for Performance Testing as Its M-BAND System Was the Only System of Its Kind Demonstrated Previously in the Field Under the DHS S&T BAND Program.
PositiveID Corporation is an emerging growth company and developer of airborne bio-threat detection systems for America’s homeland defense industry as well as advanced technologies for diabetes management and rapid medical testing. Its wholly-owned subsidiary, Microfluidic Systems, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.